Clincosm LogoSign in Get a demo

Ovarian Carcinoma

Showing 1 - 25 of 105
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Carcinoma Trial in New Haven (Sacituzumab govitecan)

Not yet recruiting
  • Ovarian Carcinoma
  • Sacituzumab govitecan
  • New Haven, Connecticut
    Smilow Cancer Hospital at Yale New Haven
Aug 31, 2023

Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +18 more
  • Clinical Encounter
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jul 24, 2023

Renal Cell Carcinoma, Ovarian Carcinoma, Thyroid Carcinoma Trial in Groningen (Olaparib, Lenvatinib, Sunitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Groningen, Netherlands
    University Medical Center Groningen
Jul 13, 2023

Sentinel Lymph Node, Ovarian Carcinoma Trial in Istanbul (Sentinel lymph node biopsy (using sterile charcoal stain) in early

Recruiting
  • Sentinel Lymph Node
  • Ovarian Carcinoma
  • Sentinel lymph node biopsy (using sterile charcoal stain) in early ovarian cancer
  • Istanbul, Turkey
    Istanbul University
Jun 25, 2023

Epithelial Ovarian Cancer, Ovarian Carcinoma Trial in Nijmegen (XP-DC vaccinations)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Ovarian Carcinoma
  • XP-DC vaccinations
  • Nijmegen, Gelderland, Netherlands
    Radboud University Medical Center
Mar 6, 2023

Ovarian Carcinoma Trial (PEP-DC1, OC-DC, PEP-DC2)

Not yet recruiting
  • Ovarian Carcinoma
  • PEP-DC1
  • +3 more
  • (no location specified)
Jan 26, 2023

Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

Recruiting
  • Colorectal Carcinoma
  • +21 more
  • Dual X-ray Absorptiometry
  • +2 more
  • Birmingham, Alabama
  • +18 more
Jan 30, 2023

High-grade Serous Ovarian Carcinoma, Ovarian Carcinoma Trial in Worldwide (Pembrolizumab, Paclitaxel, Carboplatin)

Recruiting
  • High-grade Serous Ovarian Carcinoma
  • Ovarian Carcinoma
  • Pembrolizumab
  • +5 more
  • Aurora, Colorado
  • +37 more
Jan 19, 2023

Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors

Recruiting
  • Ovarian Carcinoma
  • Biospecimen Collection
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Germline Variant Carriers With BRCA1 or BRCA2

Recruiting
  • BRCA1 and/or BRCA2 Variant Carriers
  • +3 more
    • Okayama, Japan
      Okayama University
    Dec 25, 2022

    Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +28 more
    • Conroe, Texas
    • +4 more
    Dec 5, 2022

    Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Los Angeles (Computed Tomography, Gallium Ga 68 FAPi-46,

    Recruiting
    • Breast Carcinoma
    • +10 more
    • Computed Tomography
    • +4 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Nov 29, 2022

    Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

    Completed
    • Melanoma
    • +27 more
    • XmAb20717
    • Los Angeles, California
    • +16 more
    Nov 29, 2022

    Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.

    Recruiting
    • Pelvic Cancer
    • +8 more
    • Ultrasound guided tru-cut biopsy
    • Leuven, Belgium
    • +3 more
    Nov 3, 2022

    Ovarian Carcinoma Trial in Tanta (Itraconazole capsule, Placebo)

    Not yet recruiting
    • Ovarian Carcinoma
    • Itraconazole capsule
    • Placebo
    • Tanta, Egypt
      Tanta University, Faculty of Pharmacy
    Oct 20, 2022

    Malignant Ovarian Tumor, Ovarian Carcinoma Trial in Houston (Dynamic Enhanced CT, Magnetic Resonance Imaging, Positron Emission

    Recruiting
    • Malignant Ovarian Neoplasm
    • Ovarian Carcinoma
    • Dynamic Enhanced CT
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2022

    Epithelial Cell Adhesion Molecule in Epithelial Ovarian

    Recruiting
    • Ovarian Carcinoma
      • Sohag, Egypt
      • +1 more
      Oct 8, 2022

      Non-small-cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck, Renal Cell Carcinoma Trial in United States

      Active, not recruiting
      • Non-small-cell Lung Cancer
      • +5 more
      • PF-07209960
      • Duarte, California
      • +11 more
      Oct 10, 2022

      Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer Trial in Baltimore (procedure, drug, other)

      Recruiting
      • Stage III Ovarian Cancer
      • +6 more
      • Cytoreductive Surgery (CRS)
      • +6 more
      • Baltimore, Maryland
        Mercy Medical Center
      Aug 30, 2022

      Breast Carcinoma, Fallopian Tube Carcinoma, Ovarian Carcinoma Trial in Houston (Computed Tomography, Fludeoxyglucose F-18,

      Recruiting
      • Breast Carcinoma
      • +7 more
      • Computed Tomography
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 24, 2022

      Patients With Low Grade Ovarian or Peritoneal Tumors

      Recruiting
      • Low Grade Ovarian Serous Adenocarcinoma
      • +5 more
      • Biospecimen Collection
      • Electronic Health Record Review
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 18, 2022

      Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

      Recruiting
      • Ovarian Cancer
      • +68 more
      • Phoenix, Arizona
      • +8 more
      Aug 18, 2022

      Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

      Recruiting
      • Advanced Malignant Solid Neoplasm
      • +49 more
      • Birmingham, Alabama
      • +1429 more
      Aug 17, 2022

      Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma Trial (AMT-151)

      Not yet recruiting
      • Advanced Solid Tumor
      • +18 more
      • (no location specified)
      Aug 10, 2022

      Ovarian Cancer, Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial (Pamiparib, Surufatinib)

      Not yet recruiting
      • Ovarian Cancer
      • +4 more
      • (no location specified)
      Aug 8, 2022